Serum Institute of India chief executive officer Adar Poonawalla on Saturday said the vaccine was cheaper than most covid-19 treatments, and increasing its price was necessary to keep its production sustainable.The company will charge ₹400 per dose for Covishield from the Centre and states for fresh orders and ₹600 per dose from private hospitals from 1 May.“Only a limited portion of SII's volume will be sold to private hospitals at INR 600 per dose.
The price of the vaccine is still lower than a lot of other medical treatment and essentials required to treat covid-19 and other life-threatening diseases," Serum Institute of India said in the statement.He said that the new pricing was announced after identifying the uncertainty due to.